Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Centis

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 2, 2009
Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring toolG B Migliori, G Sotgiu, E Jaramillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?G B Migliori, R Centis, L D'Ambrosio, et al.
Pulmonology|December 26, 2017
Tuberculosis, social determinants and co-morbidities (including HIV)R Duarte, K Lönnroth, C Carvalho, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 3, 2026
The prevalence of post-TB bronchiectasis: lessons from the Spanish registeriesG Oscullo, M A Martinez-García, R Centis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 27, 2024
Evaluation of effectiveness and safety of delamanid-containing regimens using individual patient datasetsD R Silva, R Centis, L D'Ambrosio, et al.
Pulmonology|October 2, 2023
Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TBA Oehadian, M L Bastos, R Centis, et al.
The European Respiratory Journal|September 2, 2009
MDR-TB and XDR-TB: drug resistance and treatment outcomesG B Migliori, G Sotgiu, M D'Arcy Richardson, et al.
The European Respiratory Journal|July 3, 2010
Development of a standardised tool to survey MDR-/XDR-TB case management in EuropeG Sotgiu, R Centis, L D'ambrosio, et al.
The European Respiratory Journal|February 7, 2003
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000G B Migliori, R Centis, L Fattorini, et al.
Cardiologia (Rome, Italy)|January 1, 1983
[Activity of serum enzymes in intracoronary thrombolysis: preliminary study]L Compostella, F Bellotto, R Chioin, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 2, 2009
Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring toolG B Migliori, G Sotgiu, E Jaramillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?G B Migliori, R Centis, L D'Ambrosio, et al.
Pulmonology|December 26, 2017
Tuberculosis, social determinants and co-morbidities (including HIV)R Duarte, K Lönnroth, C Carvalho, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 3, 2026
The prevalence of post-TB bronchiectasis: lessons from the Spanish registeriesG Oscullo, M A Martinez-García, R Centis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 27, 2024
Evaluation of effectiveness and safety of delamanid-containing regimens using individual patient datasetsD R Silva, R Centis, L D'Ambrosio, et al.
Pulmonology|October 2, 2023
Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TBA Oehadian, M L Bastos, R Centis, et al.
The European Respiratory Journal|September 2, 2009
MDR-TB and XDR-TB: drug resistance and treatment outcomesG B Migliori, G Sotgiu, M D'Arcy Richardson, et al.
The European Respiratory Journal|July 3, 2010
Development of a standardised tool to survey MDR-/XDR-TB case management in EuropeG Sotgiu, R Centis, L D'ambrosio, et al.
The European Respiratory Journal|February 7, 2003
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000G B Migliori, R Centis, L Fattorini, et al.
Cardiologia (Rome, Italy)|January 1, 1983
[Activity of serum enzymes in intracoronary thrombolysis: preliminary study]L Compostella, F Bellotto, R Chioin, et al.
Pageof 8